Geng C, Zhang MC, Manyam GC, Vykoukal JV, et al. SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression. Clin Cancer Res 2023 Aug 15:CCR-23-1439. doi: 10.1158/1078-0432.CCR-23-1439.
PMID: 37581614